홈
마켓
차트 & 아이디어
Algo
뉴스
Store
브로커
다운로드
경제 달력
트레이딩 시그널
웹터미널
검색
/
타입: @user, $symbol
검색
로그인
계정을 생성하십시오
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CGTX
#3362
Cognition Therapeutics, Inc. Common Stock
1.0
9
-5.22%
부문:
베이스:
수익 통화:
일일 변동 비율
년간 변동
일일 변동
-5.22%
월간 변동
-18.66%
6달 변화
-58.87%
년간 변동율
+142.22%
이전 종가
1.1
5
Open
1.0
9
Bid
Ask
Low
1.0
9
High
1.0
9
양
16
마켓
주식
헬스케어
CGTX
Open full chart
Financials
Overview
성명
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Key stats
Total common shares outstanding
41.55 M
61.97 M
61.99 M
73.47 M
88.27 M
—
Valuation ratios
Enterprise value
-2.54 M
18.45 M
9.66 M
12.02 M
79.84 M
119.97 M
Price to earnings ratio
-0.49
-0.82
-0.59
-0.48
-3
-4.89
Price to sales ratio
-90.39
-142.89
—
—
—
—
Price to cash flow ratio
0.65
0.98
0.61
0.49
2.54
4.62
Price to book ratio
0.18
1.49
0.26
0.27
1.08
3.1
Enterprise value to EBITDA ratio
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.36
-0.26
-0.36
-0.34
-0.11
-1.08
Return on equity %
-0.69
-0.42
-0.69
-0.96
-0.13
-2.2
Return on invested capital %
—
—
—
—
—
—
Gross margin %
—
—
—
—
—
—
Operating margin %
—
—
—
—
—
—
EBITDA margin %
—
—
—
—
—
—
Net margin %
—
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
Current ratio
2.11
2.65
2.09
1.54
6.44
12.73
Inventory turnover
—
—
—
—
—
—
Asset turnover
0
0
—
—
—
—
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
-0.18
-0.21
-0.16
-0.09
-0.08
-0.54
EBIT per share
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
Cash per share
0.58
0.63
0.27
0.17
0.58
1.65
Net current asset value per share
0.7
0.74
0.37
0.31
0.64
2.06
Tangible book value per share
0.38
0.47
0.2
0.11
0.54
1.32
Working capital per share
0.37
0.46
0.19
0.11
0.54
1.3
Book value per share
0.38
0.47
0.2
0.11
0.54
1.32
뉴스
Cognition Therapeutics se reúne con la FDA sobre medicamento para demencia con cuerpos de Lewy
Cognition Therapeutics holds FDA meeting on Lewy bodies dementia drug
Fármaco de Cognition para DLB muestra resultados positivos en ensayo fase 2
Cognition’s DLB drug shows positive results in phase 2 trial
Cognition Therapeutics completa inscripción en programa de acceso expandido
Cognition Therapeutics completes enrollment in expanded access program
Cognition Therapeutics describe planes para Fase 3 de medicamento contra Alzheimer
Cognition Therapeutics detalla planes de Fase 3 para fármaco contra Alzheimer
Cognition Therapeutics outlines Phase 3 plans for Alzheimer’s drug
Cognition Therapeutics: A High-Stakes Bet On A Single Drug - Why I Hold (NASDAQ:CGTX)
Cognition Therapeutics completa inscripción en ensayo de fármaco para Alzheimer
Cognition Therapeutics completa inscripción en ensayo de fármaco para Alzheimer